North China Pharmaceutical (600812.SH): Marketing application for cefradine API approved

Zhitong Finance APP News, North China Pharmaceutical (600812.SH) announced that recently, the company received the "Chemical API Marketing Application Approval Notice" for cefradine approved and issued by the National Medical Products Administration. Cefradine is an oral cephalosporin antibiotic, and its oral formulations are used for respiratory tract infections caused by susceptible bacteria, including acute pharyngitis, tonsillitis, otitis media, bronchitis, and mild pneumonia, and can also be used for common mild-to-moderate bacterial infections of the genitourinary tract and skin and soft tissues.